Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers-Reference-Cited by-同舟云学术

Clinical Significance of HER2 Overexpression in Gastric and Gastroesophageal Junction Cancers

Published:2015-07-16 Issue:9 Volume:19 Page:1565-1571
ISSN:1091-255X
Container-title:Journal of Gastrointestinal Surgery
language:en
Short-container-title:J Gastrointest Surg

Author:

Baykara Meltem, ,Benekli Mustafa,Ekinci Ozgur,Irkkan Sultan Cigdem,Karaca Halit,Demirci Umut,Akinci Muhammed Bulent,Unal Olcun Umit,Dane Faysal,Turkoz Fatma Paksoy,Balakan Ozan,Eser Eylem Pinar,Ozturk Selcuk Cemil,Ozkan Metin,Oksuzoglu Berna,Sevinc Alper,Demir Necla,Harputluoglu Hakan,Yalcin Bulent,Coskun Ugur,Uner Aytug,Ozet Ahmet,Buyukberber Suleyman

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s11605-015-2888-y.pdf

Reference41 articles.

1. International Agency for Research on Cancer (IARC). http://www.dep.iarc.fr/globocan .

2. Yarden Y. The EGFR family and its ligands in human cancer: signaling mechanisms and therapeutic opportunities. Eur J Cancer. 2001;37 Suppl 4:S3-S8.

3. Barnes CJ, Kumar R. Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets. Cancer Metastasis Rev. 2003;22:301-307.

4. Gravalos C, Jimeno A. HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target. Ann Oncol. 2008;19:1523-1529.

5. Sakai K, Mori S, Kawamoto T, Taniguchi S, Kobori O, Morioka Y, Kuroki T, Kano K. Expression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomas. J Natl Cancer Inst. 1986;77:1047-1052.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Construction of a prognostic model for autophagy in Wilm's tumor;Pediatric Surgery International;2024-05-04

2. Neoadjuvant chemoimmunotherapy in locally advanced gastric or gastroesophageal junction adenocarcinoma;Frontiers in Oncology;2024-04-15

3. Impact of HER2-Low Status in Metastatic Gastric Cancer: A Real-World Retrospective Cohort Study;Oncology;2024-02-14

4. Immunotherapeutic strategy in the management of gastric cancer: molecular profiles, current practice, and ongoing trials;Journal of the Egyptian National Cancer Institute;2023-10-02

5. HER2-Positive Gastric Cancer: The Role of Immunotherapy and Novel Therapeutic Strategies;International Journal of Molecular Sciences;2023-07-13